JAMA Network
About The Study: In this cluster randomized trial, within the context of the late COVID-19 pandemic period and limited school and general practitioner participation, at-school human papillomavirus (HPV) vaccination significantly increased vaccination coverage. The trial did not show a significant effect for training general practitioners and education and motivation, although it may be observed after more time has elapsed after the intervention.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
